| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |